Global Heart Failure Academy

Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.
To return to the Global Heart Failure Academy, please click here.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from Vifor Pharma.

Episodes 1-16 of 17

- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
1
CME/CE
From Guidelines to Practice: Key Updates From 2021 HFSA
From Guidelines to Practice: Key Updates From 2021 HFSA
0.25 credits
From Guidelines to Practice: Key Updates From 2021 HFSA
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Gregg C. Fonarow, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
2
CME/CE
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes
1.50 credits
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities...
1.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
- Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
  Peer
5
CME/CE
A New Normal? COVID-19 and HF in Clinical Trials
A New Normal? COVID-19 and HF in Clinical Trials
0.25 credits
A New Normal? COVID-19 and HF in Clinical Trials
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
- Peter van der Meer, MD, PhD
  Peer
3
CME/CE
A Clinical Guide to the Role of Iron in HF Pathophysiology
A Clinical Guide to the Role of Iron in HF Pathophysiology
0.25 credits
A Clinical Guide to the Role of Iron in HF Pathophysiology
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
3
CME/CE
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders
0.25 credits
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium...
0.25 credits
- Gregory Lewis, MD
  Peer
- Michael Böhm, MD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
6
CME/CE
Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF
Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF
0.25 credits
Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF
0.25 credits
- Gregory Lewis, MD
  Peer
- Michael Böhm, MD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
12
CME/CE
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
0.25 credits
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
- Gerasimos Filippatos, MD, FESC, FHFA
  Peer
6
CME/CE
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
0.25 credits
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
0.25 credits
- Michael Böhm, MD, FESC
  Peer
4
Global Heart Failure Academy
AFFIRM-AHF: Wichtige Punkte
AFFIRM-AHF: Wichtige Punkte
AFFIRM-AHF: Wichtige Punkte
- Michael Böhm, MD, FESC
  Peer
10
Global Heart Failure Academy
CARE HK bei HF: Entwurf einer Studie aus der Praxis zur Identifizierung von Barrieren für die leitliniengesteuerte RAASi-Therapie
CARE HK bei HF: Entwurf einer Studie aus der Praxis zur Identifizierung von Barrieren für die leitliniengesteuerte RAASi-Therapie
CARE HK bei HF: Entwurf einer Studie aus der Praxis zur Identifizierung von B...
- Javed Butler, MD, MBA, MPH
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
- Gerasimos Filippatos, MD, FESC, FHFA
  Peer
13
CME/CE
AHA 2020: New Insights on Iron Deficiency and Heart Failure
AHA 2020: New Insights on Iron Deficiency and Heart Failure
0.25 credits
AHA 2020: New Insights on Iron Deficiency and Heart Failure
0.25 credits
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
8
Global Heart Failure Academy
AFFIRM-AHF: Key Takeaways
AFFIRM-AHF: Key Takeaways
AFFIRM-AHF: Key Takeaways
- Stefan D. Anker, MD, PhD
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
11
Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
- Javed Butler, MD, MBA, MPH
  Peer
- Peter van der Meer, MD, PhD
  Peer
3
CME/CE
Häufige Irrtümer über Eisenmangel bei Herzinsuffizienz und dessen Behandlung
Häufige Irrtümer über Eisenmangel bei Herzinsuffizienz und dessen Behandlung
0.25 credits
Häufige Irrtümer über Eisenmangel bei Herzinsuffizienz und dessen Behandlung
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Peter van der Meer, MD, PhD
  Peer
12
CME/CE
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It
0.25 credits
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do A...
0.25 credits
2
Global Heart Failure Academy
Balancing RAASi Therapy and Potassium: Understanding How it Works
Balancing RAASi Therapy and Potassium: Understanding How it Works
Balancing RAASi Therapy and Potassium: Understanding How it Works